New promising treatments for Alzheimer's disease in Greece
Published
A significant development in the field of medicine is taking place in Greece, as new drugs for treating Alzheimer's disease are now available. These are the substances lecanemab and donanemab, which have received official approval from the relevant European Union authorities.
These specific drugs represent a new approach to treating the disease and aim to slow its progression. It is important to emphasize that these treatments are not intended for all patients, but rather for those in the early stages of Alzheimer's disease.
The administration of these drugs will take place in selected hospitals in the country, under the strict supervision of specialized doctors. Patients interested in finding out if they meet the criteria to receive the new treatment should consult their attending physicians.
The arrival of these drugs in Greece offers a new perspective for patients and their families. Despite the fact that the disease remains a major challenge, scientific progress now provides doctors with more tools to manage the condition in its initial stages.
Sources: Skai.gr
More Greece news
- The electric Renault 5 gains greater range and arrives in Greece with a special Roland-Garros edition
- Greece to contribute €120 million to European fund for high-tech companies
- Decline in technology and artificial intelligence stocks: How exposed are Greek companies?
- Meeting of Fidan and Güler on the cable across three capitals
- Interview Poll: New Democracy First with 29.4%, Ten Parties in Parliament
- Greece-Cyprus Cable: What Hatzidakis Said About France's License
- Conference on Access to Healthcare: Stelios Kymbouropoulos on the Today Press panel
- Georgia Parasxou at the Health Access Greece conference